Document is current
Any future updates will be listed below
-
Authors
Cross, Fernanda L. https://orcid.org/0000-0002-0770-9464
Esqueda, Ana Patricia
Ku, C. P.
Hunt, Rebecca
Lucio, Joel
Williams, Charles E. II
Bailey, Sarah
Williamson, Susie
Marsh, Erica E.
Resnicow, Kenneth
-
Funding
Funding for this research was provided by:
National Institute on Minority Health and Health Disparities (R01MD016867)
National Center for Advancing Translational Sciences (UM1TR004404)
National Heart, Lung, and Blood Institute (1 OT2 HL 156812)
- License Information
-
More Information
Article History
Received: 29 March 2024
Revised: 23 August 2024
Accepted: 25 August 2024
First Online: 3 September 2024
Declarations
:
: The study was approved by the Institutional Review Board on the University of Michigan’s Health and Behavioral Science (IRB-HSBS) Institutional Review board approval HUM00198399 on September 2, 2021. All research procedures performed in CIVIC studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: After a comprehensive study discussion, verbal informed consent was obtained from all study participants. Documentation of consent was waived for this study.
: The authors affirm that human research participants provided informed consent for publication of their data.
: Dr. Erica Marsh reported receiving personal fees from Myovant Sciences and Pfizer outside the submitted work. Rev. Charles Williams is a co-investigator on the study; he is also a University of Michigan student and the co-founder and officer on the board of directors for the Institute on National Social Inequities and Gaps in Health and Health Treatment (DBA “INSIGHT”). INSIGHT is a collaborator on this study.No other disclosures are reported. There are no other conflicts to report.
